Samsung BioLogics surpassed 2 trillion won in cumulative sales in the third quarter. It exceeded 1.568 trillion won in annual sales last year in three quarters. On the 26th, Samsung BioLogics announced that it achieved 873 billion won in sales and 324.7 billion won in operating profit in the third quarter. Both sales and operating profit rose 94% year-on-year. Cumulative sales are 2.358 trillion won on a consolidated basis. It is the first time since its foundation that Samsung BioLogics has surpassed 2 trillion won in sales.

◆ Samsung BioLogics exceeded sales last year in three quarters

Samsung BioLogics explained that it recorded cumulative sales of 1.6896 trillion won and an ope